Tiaa Fsb Has $55.11 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Tiaa Fsb raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.9% during the third quarter, Holdings Channel reports. The firm owned 141,041 shares of the healthcare conglomerate’s stock after buying an additional 7,835 shares during the period. Tiaa Fsb’s holdings in UnitedHealth Group were worth $55,111,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. SignalPoint Asset Management LLC boosted its holdings in shares of UnitedHealth Group by 3.1% in the 2nd quarter. SignalPoint Asset Management LLC now owns 786 shares of the healthcare conglomerate’s stock worth $315,000 after acquiring an additional 24 shares in the last quarter. Davis Rea LTD. boosted its holdings in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Davis Rea LTD. now owns 6,782 shares of the healthcare conglomerate’s stock worth $2,716,000 after acquiring an additional 25 shares in the last quarter. Tandem Capital Management Corp ADV boosted its holdings in shares of UnitedHealth Group by 0.9% in the 2nd quarter. Tandem Capital Management Corp ADV now owns 2,693 shares of the healthcare conglomerate’s stock worth $1,078,000 after acquiring an additional 25 shares in the last quarter. Foster Group Inc. boosted its holdings in shares of UnitedHealth Group by 1.0% in the 2nd quarter. Foster Group Inc. now owns 2,466 shares of the healthcare conglomerate’s stock worth $987,000 after acquiring an additional 25 shares in the last quarter. Finally, Waters Parkerson & CO. LLC boosted its holdings in shares of UnitedHealth Group by 3.2% in the 2nd quarter. Waters Parkerson & CO. LLC now owns 807 shares of the healthcare conglomerate’s stock worth $323,000 after acquiring an additional 25 shares in the last quarter. 86.20% of the stock is currently owned by institutional investors.

Shares of NYSE:UNH traded up $3.03 during trading on Thursday, hitting $450.16. 2,248,836 shares of the company were exchanged, compared to its average volume of 2,940,181. The stock has a market cap of $423.98 billion, a price-to-earnings ratio of 27.93, a P/E/G ratio of 1.75 and a beta of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $320.35 and a fifty-two week high of $466.00. The firm has a fifty day moving average price of $430.47 and a two-hundred day moving average price of $418.01. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.59.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, October 14th. The healthcare conglomerate reported $4.52 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $4.41 by $0.11. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. The company had revenue of $72.34 billion during the quarter, compared to the consensus estimate of $71.24 billion. During the same period in the previous year, the company posted $3.51 EPS. The firm’s revenue for the quarter was up 11.1% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 18.84 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 14th. Investors of record on Monday, December 6th will be paid a $1.45 dividend. The ex-dividend date of this dividend is Friday, December 3rd. This represents a $5.80 annualized dividend and a yield of 1.29%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.98%.

In other news, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction on Tuesday, September 14th. The stock was sold at an average price of $416.75, for a total transaction of $1,041,875.00. Following the completion of the sale, the director now directly owns 154,403 shares in the company, valued at approximately $64,347,450.25. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Stephen J. Hemsley sold 75,000 shares of the company’s stock in a transaction on Monday, October 25th. The shares were sold at an average price of $448.72, for a total value of $33,654,000.00. The disclosure for this sale can be found here. Insiders sold a total of 82,500 shares of company stock valued at $36,855,125 over the last 90 days. 0.55% of the stock is currently owned by corporate insiders.

Several research analysts recently weighed in on the stock. Cowen assumed coverage on shares of UnitedHealth Group in a research report on Thursday, September 9th. They issued an “outperform” rating and a $478.00 price objective for the company. BMO Capital Markets boosted their price objective on shares of UnitedHealth Group from $435.00 to $475.00 and gave the stock a “market perform” rating in a research report on Monday, October 18th. SVB Leerink assumed coverage on shares of UnitedHealth Group in a research report on Monday, September 27th. They issued an “outperform” rating and a $480.00 price objective for the company. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $421.00 to $477.00 and gave the stock a “buy” rating in a research report on Tuesday, November 16th. Finally, Morgan Stanley upped their target price on shares of UnitedHealth Group from $488.00 to $499.00 and gave the company an “overweight” rating in a research report on Friday, October 15th. One analyst has rated the stock with a hold rating, twenty-one have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $477.35.

UnitedHealth Group Company Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Featured Article: How do investors use RSI to grade stocks?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.